Visceral adiposity index as a predictor of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
Authors:
Open Access
- 1 May 2025
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-9
Abstract
The association between visceral adiposity index (VAI) and metabolic dysfunction-associated steatotic liver disease (MASLD) remains unestablished. Our study sought to investigate the potential relationship between VAI and MASLD risk. This study employed data from the 2017-2018 National Health and Nutrition Examination Survey (NHANES). Weighted multivariable regression models, subgroup analyses, and machine learning algorithms were used to evaluate associations and predictive performance. Higher VAI tertiles correlated with increased MASLD risk (adjusted OR for T3 vs. T1: 7.08, 95% CI: 4.35-11.5; P-trend=0.003). Machine learning models demonstrated robust predictive accuracy, with random forest (AUC=0.869) and gradient boosting machine (AUC=0.868) outperforming non-invasive scores. However, lipid accumulation product (LAP, AUC=0.834) and fatty liver index (FLI, AUC=0.833) achieved superior diagnostic performance compared to VAI (AUC=0.736), while maintaining clinical interpretability through simplicity and routine parameter availability. While VAI demonstrated significant positive associations with MASLD risk, non-invasive scores like LAP and FLI emerged as superior diagnostic tools, balancing accuracy with clinical practicality.Keywords
Funding Information
- Hunan Provincial Health Commission (No.202203034641, No.202203034641, No.202203034641, No.202203034641, No.202203034641)
This publication has 35 references indexed in Scilit:
- CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in ChinaMetabolism, 2021
- Nonalcoholic Fatty Liver Disease 2020: The State of the DiseaseGastroenterology, 2020
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular DiseaseFrontiers in Cardiovascular Medicine, 2020
- Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2019
- Visceral adiposity index as a predictor of NAFLD: A prospective study with 4‐year follow‐upLiver International, 2018
- Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA studyNutrition, Metabolism and Cardiovascular Diseases, 2017
- Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patientsWorld Journal of Gastroenterology, 2013
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010